Human antibodies against West Nile and related orthoflaviviruses

West Nile virus (WNV) is a mosquito-borne pathogen of global concern that can cause fatal neuroinvasive disease. No specific prophylaxis or treatment exists for WNV or related orthoflavivirus infections, and the determinants of human disease severity remain poorly understood. Here, we report that neutralizing autoantibodies against type I interferons do not impair antiviral antibody development. Among the fully human monoclonal antibodies with potent neutralizing activity against WNV that were discovered, W010 targets a unique epitope within the envelope protein domain III (EDIII) and confers both pre- and post-exposure protection in a murine WNV model, even when interferon signaling is impaired. A second protective antibody, W014, exhibits broad cross-neutralization of other pathogenic orthoflavivirus members, including Japanese encephalitis virus, Murray Valley encephalitis virus, Saint Louis encephalitis virus, and Usutu virus. These findings identify key neutralizing epitopes on WNV EDIII and provide candidates for the development of antibody-based interventions against encephalitic orthoflavivirus infections.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-04-06
DOI
https://doi.org/10.64898/2026.04.02.715800
Primary Topic
Mosquito-borne diseases and control
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human antibodies against West Nile and related orthoflaviviruses

Dragana Mijatović, Benjamin G. Hale, Václav Hönig, Siniša Sević et al.
bioRxiv (Cold Spring Harbor Laboratory)
Mosquito-borne diseases and control
article

Human antibodies against West Nile and related orthoflaviviruses

Dragana Mijatović, Benjamin G. Hale, Václav Hönig, Siniša Sević, Zorana Budakov-Obradović, Jagoda Gavrilović, Jacques Moritz, Jiří Holoubek, Stylianos Bournazos, Margaret R. MacDonald, Davide F. Robbiani, Zaria I. Contejean, Christopher O. Barnes, Dajana Lendak, Tania Kapoor, Kevin Groen, Zvezdana Lojpur, Pavle Banović, Simone G. Moro, Monika Bajči, Luca Simonelli, Martin Palus, Jasmina Grujić, Luca Varani, Tomás Cervantes Rincón, Roger Kuratli, Monika Čížková, Zuzana Krátka, Benedetta Cena, Jasmine Cantergiani, Tereza Frčková, Emily G. Niejadlik, Roshan Thakur, David Jarrossay, Lidija Popovic-Dragonjic, Marija Vranes, Filippo Bianchini, Anna R. E. Robinson, Jiri Salat, Daniel Ruzek, Silvia Tosolini
article en

Abstract

West Nile virus (WNV) is a mosquito-borne pathogen of global concern that can cause fatal neuroinvasive disease. No specific prophylaxis or treatment exists for WNV or related orthoflavivirus infections, and the determinants of human disease severity remain poorly understood. Here, we report that neutralizing autoantibodies against type I interferons do not impair antiviral antibody development. Among the fully human monoclonal antibodies with potent neutralizing activity against WNV that were discovered, W010 targets a unique epitope within the envelope protein domain III (EDIII) and confers both pre- and post-exposure protection in a murine WNV model, even when interferon signaling is impaired. A second protective antibody, W014, exhibits broad cross-neutralization of other pathogenic orthoflavivirus members, including Japanese encephalitis virus, Murray Valley encephalitis virus, Saint Louis encephalitis virus, and Usutu virus. These findings identify key neutralizing epitopes on WNV EDIII and provide candidates for the development of antibody-based interventions against encephalitic orthoflavivirus infections.

bioRxiv (Cold Spring Harbor Laboratory)
University of Kragujevac (RS), University of Nis (RS), University of Novi Sad (RS), University of Zurich (CH), Masaryk University (CZ), Klinički centar Vojvodine (RS), University of South Bohemia in České Budějovice (CZ), Veterinary Research Institute (CZ), Chan Zuckerberg Initiative (United States) (US), Stanford Medicine (US), Clinical Centre of Kragujevac (RS), Institute of Parasitology (CZ), Czech Academy of Sciences, Biology Centre (CZ), Università della Svizzera italiana (CH), Rockefeller University (US), Stanford University (US)
National Science Foundation, Rita Allen Foundation, European Commission, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Grantová Agentura České Republiky, Akademie Věd České Republiky, Swiss Vaccine Research Institute, National Institutes of Health, National Institute of General Medical Sciences
Good health and well-being
Openalex Percentile: Top 26%
Mosquito-borne diseases and control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.